US 12214015
Use of c-type natriuretic peptide variants to treat osteoarthritis
granted A61KA61K31/573A61K31/728
Quick answer
US patent 12214015 (Use of c-type natriuretic peptide variants to treat osteoarthritis) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/573, A61K31/728, A61K38/22, A61K38/2242